The U.S. Supreme Court agreed to hear Hikma v. Amarin to answer a narrow question. It may end up saying far more about how policymakers misunderstand pharmaceutical markets. On its face, the case is narrow. It asks whether a generic drug manufacturer can face liability for inducing patent infringement based on how it markets a…
Stuf reported: Government proposes sweeping changes to alcohol laws The changes are far from sweeping. They are good, and tidy up some stupid stuff, but it is not a major change. As I said, all pretty minor but useful changes. It is good that someone living in Auckland can’t object anymore to an application in…
Health care spending had been a rising share of US GDP for decades, but since about 2010, the rate of increase seemed to level out. David M. Cutler and Lev Klarnet address “Has the United States bent the health care cost curve?” (Brookings Papers on Economic Activity, Spring 2026, readable overview of paper at link, including a…
This paper examines China’s transition from pharmaceutical “free rider” to global innovator over the last decade. In 2010, China accounted for less than 8% of global clinical trials; by 2020, it had surpassed the US in annual registered clinical trial volume. To study this transformation, we compile a comprehensive, synchronized database spanning the pharmaceutical drug…
The final phase of the Covid inquiry is out, and almost nobody will be fully happy with what it says. The report says New Zealand got plenty right, but it also lays out a string of failures, blind spots and overreaches. It is neither the devastating indictment that opponents of the Labour government wanted, nor […]
The Royal Commission has released their second and final report. Some key aspects: Simeon Brown points out: The post Covid-19 Royal Commission report released first appeared on Kiwiblog.
The Telegraph has written a guide for vapers travelling to parts of the world that are even more hostile to e-cigarettes. I am quoted in it. Christopher Snowdon, head of lifestyle economics at the Institute of Economic Affairs and editor of the Nanny State Index, which ranks countries by how much they interfere with people’s lifestyle…
Finding out that GLP-1 drugs can help reduce weight has been life changing for many and could stem the social costs of being overweight. Recently, prices have fallen dramatically. I asked ChatGPT to for some summary data for Wegovy & Zepbound which I plot below. Competition matters. Initially, Wegovy was the effective monopolist selling at a list price…
See The Weight-Loss Price Wars Are Breaking Big Pharma’s Business Model: Prices for GLP-1s are falling fast and forcing companies to adapt by David Wainer of The WSJ.”Two years ago, a GLP-1 prescription could cost an uninsured patient more than $1,000 a month. Today, Novo Nordisk’s Wegovy pill starts at just $149 through cash-pay programs.””Typically, drug…
For two reasons I think that Jesse Singal‘s long op-ed (really a “guest essay”) in today’s NYT will mark a turning point in public and professional attitudes towards “affirmative care.” First, the NYT saw fit to publish a piece showing that many American medical associations have promoted “affirmative care” of gender-dysphoric adolescents, despite those associations…
Most people know that the number of drinkers and smokers is in decline in the UK, but you might be surprised to hear that the same is true of gamblers. For the first time since the early 1990s, gamblers are in the minority with only 48% of English adults engaging in any gambling activity in…
The Herald reports on Scott Watson: That’s a pretty good sign that Watson shouldn’t be released. Unprovoked violence. And they also report on Clayton Weatherston: The reports referred to his diagnosis of narcissistic personality disorder – specifically characterised as “gross narcissism”. They also mentioned “psychopathy” and categorised Weatherston as being a high risk of reoffending. …
I used to subscribe to the New York Review of Books, which, while sometimes a repository for boring academic cat-fights, often included engaging and illuminating articles—until fabled editor Bob Silvers died in 2017. Now, under the leadership of editor Emily Greenhouse, the magazine, always Left-leaning, seems to have become more progressive. The article by gender…
Pharmaceuticals have high fixed costs of R&D and low marginal costs. The first pill costs a billion dollars; the second costs 50 cents. That cost structure makes price discrimination—charging different customers different prices based on willingness to pay—common. Price discrimination is why poorer countries get lower prices. Not because firms are charitable, but because a…
Why Evolution is True is a blog written by Jerry Coyne, centered on evolution and biology but also dealing with diverse topics like politics, culture, and cats.
In Hume’s spirit, I will attempt to serve as an ambassador from my world of economics, and help in “finding topics of conversation fit for the entertainment of rational creatures.”
“We do not believe any group of men adequate enough or wise enough to operate without scrutiny or without criticism. We know that the only way to avoid error is to detect it, that the only way to detect it is to be free to inquire. We know that in secrecy error undetected will flourish and subvert”. - J Robert Oppenheimer.
Recent Comments